Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $40.6500 (0.94%) ($40.6500 - $40.6500) on Fri. Nov. 5, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.91% (three month average) | RSI | 72 | Latest Price | $40.6500(0.94%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.3% a day on average for past five trading days. | Weekly Trend | HALO advances 2.2% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(50%) IWM(48%) IWC(45%) IWN(45%) | Factors Impacting HALO price | HALO will decline at least -0.955% in a week (0% probabilities). VIXM(-29%) VXX(-10%) UUP(-10%) GLD(-3%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.955% (StdDev 1.91%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $39.91(1.85%) | 10 Day Moving Average | $39.06(4.07%) | 20 Day Moving Average | $38.49(5.61%) | To recent high | -5.3% | To recent low | 11.2% | Market Cap | $5.556b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |